Sprint Bioscience AB (publ) (5JA1.F)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Johan Emilsson | Chief Executive Officer | 1.68M | -- | 1984 |
| Prof. Pär Nordlund | Founder | 25k | -- | 1958 |
| Dr. Martin Andersson | Co-Founder & Chief Scientific Officer | -- | -- | 1971 |
| Dr. Kenth Hallberg | Founder & Director of Structural Chemistry | -- | -- | 1971 |
| Mr. Niklas Axelsson | Chief Financial Officer | -- | -- | 1973 |
| Ms. Anne-Marie Wenthzel | Chief Business Officer | -- | -- | 1964 |
Sprint Bioscience AB (publ)
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 38
Description
Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden. The company develops VPS34, a drug candidate for the treatment of various types of cancer by using immunotherapies; TREX1, a drug candidate for the treatment of immuno-oncology, radiotherapy and chemotherapy in the treatment of cancer. It also develops PETRA01, a drug candidate for the treatment of cancer. In addition, the company focuses on research of products for the treatment of tumor metabolism and nash. Sprint Bioscience AB (publ) was incorporated in 2009 and is based in Huddinge, Sweden.
Corporate Governance
Upcoming Events
May 7, 2025 at 10:59 AM UTC
Sprint Bioscience AB (publ) Earnings Date
Recent Events
Recent Events Information Not Available